608 related articles for article (PubMed ID: 7581450)
1. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice.
Adlkofer K; Martini R; Aguzzi A; Zielasek J; Toyka KV; Suter U
Nat Genet; 1995 Nov; 11(3):274-80. PubMed ID: 7581450
[TBL] [Abstract][Full Text] [Related]
2. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
Naef R; Suter U
Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mouse models of CMT1A and HNPP.
Suter U; Nave KA
Ann N Y Acad Sci; 1999 Sep; 883():247-53. PubMed ID: 10586249
[TBL] [Abstract][Full Text] [Related]
4. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
[TBL] [Abstract][Full Text] [Related]
5. A transgenic mouse model for human hereditary neuropathy with liability to pressure palsies.
Maycox PR; Ortuño D; Burrola P; Kuhn R; Bieri PL; Arrezo JC; Lemke G
Mol Cell Neurosci; 1997; 8(6):405-16. PubMed ID: 9143558
[TBL] [Abstract][Full Text] [Related]
6. [Hereditary neuropathy with liability to pressure palsies: study of six Spanish families].
Pou Serradell A; Monells J; Téllez MJ; Fossas P; Löfgren A; Meuleman J; Timmerman V; De Jonghe P; Ceuterick C; Martin JJ
Rev Neurol (Paris); 2002 May; 158(5 Pt 1):579-88. PubMed ID: 12072826
[TBL] [Abstract][Full Text] [Related]
7. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
Maier M; Berger P; Nave KA; Suter U
Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
[TBL] [Abstract][Full Text] [Related]
8. Inherited peripheral neuropathy.
Keller MP; Chance PF
Semin Neurol; 1999; 19(4):353-62. PubMed ID: 10716658
[TBL] [Abstract][Full Text] [Related]
9. A newly identified Thr99fsX110 mutation in the PMP22 gene associated with an atypical phenotype of the hereditary neuropathy with liability to pressure palsies.
Moszyńska I; Kabzińska D; Sinkiewicz-Darol E; Kochański A
Acta Biochim Pol; 2009; 56(4):627-30. PubMed ID: 19830275
[TBL] [Abstract][Full Text] [Related]
10. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
[TBL] [Abstract][Full Text] [Related]
11. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies.
Li J; Ghandour K; Radovanovic D; Shy RR; Krajewski KM; Shy ME; Nicholson GA
Arch Neurol; 2007 Jul; 64(7):974-8. PubMed ID: 17620487
[TBL] [Abstract][Full Text] [Related]
12. Application of multiplex ligation-dependent probe analysis to define a small deletion encompassing PMP22 exons 4 and 5 in hereditary neuropathy with liability to pressure palsies.
Sutton IJ; Mocroft AP; Lindley VH; Barber RM; Bryon RJ; Winer JB; MacDonald F
Neuromuscul Disord; 2004 Dec; 14(12):804-9. PubMed ID: 15564036
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy.
Adlkofer K; Frei R; Neuberg DH; Zielasek J; Toyka KV; Suter U
J Neurosci; 1997 Jun; 17(12):4662-71. PubMed ID: 9169527
[TBL] [Abstract][Full Text] [Related]
14. [Molecular genetics of inherited neuropathies].
Takashima H
Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
[TBL] [Abstract][Full Text] [Related]
15. Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies.
Zielasek J; Toyka KV
Ann N Y Acad Sci; 1999 Sep; 883():310-20. PubMed ID: 10586256
[TBL] [Abstract][Full Text] [Related]
16. Myelin and axon pathology in a long-term study of PMP22-overexpressing mice.
Verhamme C; King RH; ten Asbroek AL; Muddle JR; Nourallah M; Wolterman R; Baas F; van Schaik IN
J Neuropathol Exp Neurol; 2011 May; 70(5):386-98. PubMed ID: 21487305
[TBL] [Abstract][Full Text] [Related]
17. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
Fortun J; Go JC; Li J; Amici SA; Dunn WA; Notterpek L
Neurobiol Dis; 2006 Apr; 22(1):153-64. PubMed ID: 16326107
[TBL] [Abstract][Full Text] [Related]
18. Distal axonopathy in peripheral nerves of PMP22-mutant mice.
Sancho S; Magyar JP; Aguzzi A; Suter1 U
Brain; 1999 Aug; 122 ( Pt 8)():1563-77. PubMed ID: 10430839
[TBL] [Abstract][Full Text] [Related]
19. Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons.
Maier M; Castagner F; Berger P; Suter U
Mol Cell Neurosci; 2003 Nov; 24(3):803-17. PubMed ID: 14664827
[TBL] [Abstract][Full Text] [Related]
20. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy.
Meyer zu Horste G; Prukop T; Liebetanz D; Mobius W; Nave KA; Sereda MW
Ann Neurol; 2007 Jan; 61(1):61-72. PubMed ID: 17262851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
